Canopy Growth Company Insiders
| CGC Stock | USD 1.17 0.02 1.74% |
Canopy Growth employs about 960 people. The company is managed by 35 executives with a total tenure of roughly 127 years, averaging almost 3.0 years of service per executive, having 27.43 employees per reported executive. Evaluation of Canopy Growth's management performance can provide insight into the firm performance.
| Mike Lee President Chief Financial Officer, Executive Vice President |
Canopy Growth Management Team Effectiveness
The company has Return on Asset of (0.0264) % which means that on every $100 spent on assets, it lost $0.0264. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.485) %, meaning that it generated no profit with money invested by stockholders. Canopy Growth's management efficiency ratios could be used to measure how well Canopy Growth manages its routine affairs as well as how well it operates its assets and liabilities.Canopy Growth holds a total of 377.86 Million outstanding shares. Almost 88.95 percent of Canopy Growth outstanding shares are held by general public with 0.04 (percent) owned by insiders and only 11.01 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Canopy Growth in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Canopy Growth, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Canopy Growth Workforce Comparison
Canopy Growth Corp is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 26,345. Canopy Growth holds roughly 960 in number of employees claiming about 4% of equities under Health Care industry.
The company has Net Profit Margin of (1.17) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.18) %, which entails that for every $100 of revenue, it lost $0.18. Canopy Growth Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Canopy Growth insiders, such as employees or executives, is commonly permitted as long as it does not rely on Canopy Growth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Canopy Growth insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
David Lazzarato over a month ago Disposition of 15715 shares by David Lazzarato of Canopy Growth at 1.13 subject to Rule 16b-3 | ||
David Lazzarato over three months ago Disposition of 2993 shares by David Lazzarato of Canopy Growth at 4.95 subject to Rule 16b-3 | ||
David Lazzarato over three months ago Acquisition by David Lazzarato of 267857 shares of Canopy Growth subject to Rule 16b-3 | ||
Judy Schmeling over three months ago Disposition of 18481 shares by Judy Schmeling of Canopy Growth at 0.81 subject to Rule 16b-3 | ||
Gedeon Christelle over six months ago Disposition of 16929 shares by Gedeon Christelle of Canopy Growth at 1.74 subject to Rule 16b-3 | ||
David Lazzarato over six months ago Disposition of 15701 shares by David Lazzarato of Canopy Growth at 1.23 subject to Rule 16b-3 | ||
Judy Hong over six months ago Disposition of 273 shares by Judy Hong of Canopy Growth at 1.47 subject to Rule 16b-3 | ||
Luc Mongeau over a year ago Acquisition by Luc Mongeau of 50000 shares of Canopy Growth subject to Rule 16b-3 |
Canopy Growth Notable Stakeholders
A Canopy Growth stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Canopy Growth often face trade-offs trying to please all of them. Canopy Growth's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Canopy Growth's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Luc Mongeau | CEO Director | Profile | |
| David Klein | Chief Executive Officer, Director | Profile | |
| Judy Schmeling | Independent Chairman of the Board | Profile | |
| Dave Paterson | President Cannabis | Profile | |
| Rade Kovacevic | Vice President - Sales and Customer Experience | Profile | |
| Mike Lee | Chief Financial Officer, Executive Vice President | Profile | |
| Judy Hong | Interim Chief Financial Officer | Profile | |
| David Lazzarato | Independent Director | Profile | |
| Tyler Burns | Director Relations | Profile | |
| Mark Ware | Chief Medical Officer | Profile | |
| Thomas CPA | Interim Officer | Profile | |
| Terry Yanofsky | Director | Profile | |
| FCPA FCA | Strategic Advisor | Profile | |
| Miles Worne | Managing Markets | Profile | |
| Robert Hanson | Independent Director | Profile | |
| Christelle LLB | Chief Secretary | Profile | |
| Tara Rozalowsky | Interim Chief Product Officer | Profile | |
| Chris Edwards | Chief Officer | Profile | |
| Ru Wadasinghe | Chief Information Officer | Profile | |
| Bryan Murphy | Senior Operations | Profile | |
| Chrissy McHardy | Senior Resources | Profile | |
| Andrew Bevan | Senior Sales | Profile | |
| James Sabia | Independent Director | Profile | |
| William Newlands | Independent Director | Profile | |
| Phillip Shaer | Corporate Secretary, Chief Legal Officer | Profile | |
| Theresa Yanofsky | Independent Director | Profile | |
| Julious Grant | Chief Commercial Officer | Profile | |
| Jonathan Tosto | Chief Officer | Profile | |
| Thomas IV | Senior Officer | Profile | |
| Jenny Brewer | Chief Officer | Profile | |
| Jason Green | Head Division | Profile | |
| Thomas Stewart | Chief Accounting Officer, Vice President | Profile | |
| Thomas Shipley | Senior Vice President and Chief Science Officer | Profile | |
| Jimes Sabia | Director | Profile | |
| Jurgen Bickel | MD GmbH | Profile |
About Canopy Growth Management Performance
The success or failure of an entity such as Canopy Growth Corp often depends on how effective the management is. Canopy Growth management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Canopy management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Canopy management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada. Canopy Growth operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 3151 people.
Please note, the presentation of Canopy Growth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Canopy Growth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Canopy Growth's management manipulating its earnings.
Canopy Growth Workforce Analysis
Traditionally, organizations such as Canopy Growth use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Canopy Growth within its industry.Canopy Growth Manpower Efficiency
Return on Canopy Growth Manpower
| Revenue Per Employee | 280.2K | |
| Revenue Per Executive | 7.7M | |
| Net Loss Per Employee | 629.3K | |
| Net Loss Per Executive | 17.3M | |
| Working Capital Per Employee | 208.5K | |
| Working Capital Per Executive | 5.7M |
Complementary Tools for Canopy Stock analysis
When running Canopy Growth's price analysis, check to measure Canopy Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Canopy Growth is operating at the current time. Most of Canopy Growth's value examination focuses on studying past and present price action to predict the probability of Canopy Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Canopy Growth's price. Additionally, you may evaluate how the addition of Canopy Growth to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |